SEC Form 4 · accession 0001209191-17-053586
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Fleming
Officer — SVP
Period of report
Sep 20, 2017
Accepted (ET)
Sep 21, 2017 · 3:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.70 | Sep 20, 2017 | A | 90,180 | A | — | Sep 19, 2027 | Common Stock | 90,180 | 90,180 | D |
Explanation of responses
- F1This option was granted on September 20, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 90,180 shares of Common Stock, with 25% vesting on September 20, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.